DERMBIONT
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases. It is at the intersection of two highly active sectors: dermatology and the microbiome. They harness naturally occurring microbes on the human skin that have evolved over hundreds of thousands of years to compete with pathogenic microbes (fungi, bacteria, viruses, etc.). The company was founded in 2017 and is headquartered in Boston, Massachusetts with a satellite office in Emeryville, California.
DERMBIONT
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.dermbiont.com
Total Employee:
11+
Status:
Active
Total Funding:
66.07 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default LetsEncrypt Content Delivery Network Domain Not Resolving Amazon Organization Schema Google Apps For Business Microsoft Azure DNS
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-12-21 | Chromaderm | Chromaderm acquired by DermBiont | N/A |
2020-10-21 | SeylanMED | SeylanMED acquired by DermBiont | N/A |
Investors List
Civilization Ventures
Civilization Ventures investment in Series A - DermBiont
Olive Tree Capital
Olive Tree Capital investment in Series A - DermBiont
Viking Global Investors
Viking Global Investors investment in Series A - DermBiont
Toba Capital
Toba Capital investment in Series A - DermBiont
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Series A - DermBiont
Social Starts
Social Starts investment in Debt Financing - DermBiont
Joyance Partners
Joyance Partners investment in Debt Financing - DermBiont
Valia Ventures
Valia Ventures investment in Series A - DermBiont
Zola Global Investors
Zola Global Investors investment in Series A - DermBiont
Start Capital
Start Capital investment in Series A - DermBiont
Official Site Inspections
http://www.dermbiont.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013

More informations about "DermBiont"
Overview โ DermBiont
OVERVIEW Leading a Revolution in Dermatology DermBiont is advancing targeted topical therapeutics for dermatological indications. Our products in development are all first-in-class with well-defined mechanisms of action and โฆSee details»
DermBiont - Crunchbase Company Profile & Funding
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.See details»
DermBiont Company Profile - Office Locations, Competitors ... - Craft
DermBiont has 5 employees across 2 locations and $8 m in total funding,. See insights on DermBiont including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
DermBiont 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for DermBiont. Use the PitchBook Platform to explore the full profile.See details»
DermBiont - Overview, News & Similar companies | ZoomInfo.com
Oct 25, 2023 View DermBiont (www.dermbiont.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
DermBiont - 2025 Company Profile & Team - Tracxn
Jul 3, 2025 DermBiont is a series B company based in Melrose (United States), founded in 2015 by Nichola Eliovits, Robert Brucker and Karl Beutner. It operates as a Developer of microbial โฆSee details»
DermBiont - Headquarter Location, Corporate Office Address and โฆ
Find business data of DermBiont. Know the headquarter data such: location, corporate office address and opening hours of DermBiont.See details»
DermBiont
Leading a Revolution in DermatologySign up for the latest news and insights from our teamSee details»
DermBiont - Org Chart, Teams, Culture & Jobs | The Org
View DermBiont's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
DermBiont, Inc. - VentureRadar
"DermBiont is a dermatology company leveraging skin microbiome therapeutics to treat the root cause of skin diseases. In addition to advancing DBI-001, the company has a discovery โฆSee details»
DermBiont - SymBiosis Capital Management
DermBiontโs mission is to become the worldโs leading precision dermatology company developing targeted topical therapeutics that treat, cure, and prevent diseases. DermBiontโs biotherapeutics discovery team leverages โฆSee details»
DermBiont - Funding, Financials, Valuation & Investors
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.See details»
DermBiont Raises $8M Series A to Treat the Root ... - Microbiome โฆ
Jun 19, 2019 โDermBiont is building a world class research and development organization with deep and relevant experience to discover and develop first-in-class skin microbiome โฆSee details»
Platform โ DermBiont
DermBiont's platform focuses on developing first-in-class topical therapeutics with well-defined mechanisms of action for dermatological indications.See details»
DermBiont - Massachusetts Biomedical Initiatives
DermBiont is leveraging skin microbiome therapeutics to treat, cure, and prevent skin diseases and advancing targeted topical therapeutics.See details»
Annual Report on Dermbiont's Revenue, Growth, SWOT Analysis ...
Jul 7, 2025 Dermbiont's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and employees) Dermbiont's annual revenues are $1 - $10 โฆSee details»
Leadership โ DermBiont
Co-founder & CEO at DermBiont; previously CMO at Anacor (acquired by Pfizer for $5.2 billion) and CMO at Dow Pharmaceutical Sciences (acquired by Valeant).See details»
DermBiont Raises $28 Million and Acquires Chromaderm to โฆ
Dec 21, 2021 DermBiont, Inc. , a clinical-stage biotechnology company developing targeted topical therapeutics that address the root causes of skin diseases, announced today that it has โฆSee details»
DermBiont - Profiles & Contacts - Crunchbase
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.See details»
Pipeline โ DermBiont
We are focused on developing targeted therapies that treat diseases of the skin at their root cause and fulfill the unmet needs of patients living with skin conditions. Our dermatology-focused โฆSee details»